Migalastat Hydrochloride Dispersible Tablet
AT1001-033
Phase 3 small_molecule active
Quick answer
Migalastat Hydrochloride Dispersible Tablet for Fabry disease is a Phase 3 program (small_molecule) at Amicus Therapeutics Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amicus Therapeutics Europe Limited
- Indication
- Fabry disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active